Project Overview
Project title: Single, High-dose AmBisome to Reduce Excess mortality from Cryptococcal Meningitis
Abbreviation: SHARE-CM
Start date: 01/09/2021
End date: 30/09/2026
The purpose of this project is to leverage individual and institutional experience in delivering the ACTA and AMBITION-cm short-course regimens for HIV-associated cryptococcal meningitis to facilitate widespread implementation across Botswana, Malawi, Uganda and Zimbabwe with the ultimate aim of reducing mortality from cryptococcal meningitis in real-world settings. SHARE-CM is co-funded by the Centers for Disease Control and Prevention (CDC).
Key Objectives
Team Members
Project Partners





Project Funders



